T. Nozoe et al., Significance of allogenic blood transfusion on decreased survival in patients with esophageal carcinoma, CANCER, 92(7), 2001, pp. 1913-1918
BACKGROUND. To the authors' knowledge, the significance of allogenic blood
transfusion in the prognosis of patients with esophageal carcinoma remains
controversial. The objective of the current study was to elucidate the corr
elation, if any, between intraoperative allogenic blood transfusion and pro
gnosis in patients with esophageal carcinoma.
METHODS. Two hundred fifty-nine patients with esophageal carcinoma who had
undergone esophagectomy and reconstruction were studied. The clinicopatholo
gic data and survival were compared between the 87 patients (33.6%) who rec
eived an intraoperative allogenic blood transfusion and the 172 patients (6
6.4%) who did not.
RESULTS. Multivariate analysis demonstrated that the factors that appeared
to independently determine prognosis in patients with esophageal carcinoma
were the depth of the tumor (P = 0.0001), lymph node metastasis (P < 0.0001
), lymphatic invasion (P = 0.0002), venous invasion (P = 0.0008). and the o
ccurrence of postoperative complications (P = 0.034). Intraoperative alloge
nic blood transfusion was not found to be an independent prognostic indicat
or.
CONCLUSIONS. In the current study, an advanced stage of disease at the time
of surgery, which resulted in the need for blood transfusion and the occur
rence of postoperative complications, appeared to worsen the prognosis in p
atients with esophageal carcinoma. (C) 2001 American Cancer Society.